Better disease prediction, faster and at lower cost

  • 70% Accuracy predicting disease 10 years ahead
  • 2M Parameter model—small, fast, and cost-effective
  • 3 days From publication to running live on Teradata
개요

A 2-million-parameter model that could transform how healthcare systems plan

Researchers at the European Molecular Biology Laboratory and the German Cancer Research Center developed Delphi 2M—a small language model adapted to predict the diseases a patient will develop up to 10 years in the future, with up to 70% accuracy. Teradata's forward-deployed engineering team, leveraging nPath and Bring Your Own Model (BYOM) technologies, had the model running on Teradata just three days after it was published—demonstrating the speed and power of Teradata's AI platform for healthcare innovation. 

  • Delphi 2M repurposes transformer architecture to process longitudinal patient data
  • The model predicts future disease onset across patient cohorts at aggregate scale
  • Teradata's BYOM enables in-database deployment of task-specific small language models
  • nPath technology enables powerful analysis of patient journey sequence data
도전

Healthcare systems struggle to forecast demand as populations age and costs rise

Caring for aging populations across many geographies places mounting pressure on healthcare systems to plan services more accurately and cost-effectively. Traditional demand forecasting methods lack the predictive depth needed to anticipate which services different patient cohorts will require—and when. Meanwhile, deploying AI in large enterprises has historically been bottlenecked by the high cost of inference at scale, making large language models impractical for many real-world healthcare applications. 

  • Aging population demographics are straining healthcare planning and resource allocation
  • Conventional forecasting cannot predict disease onset at the individual or cohort level
  • Large language model inference costs are prohibitive for enterprise-scale healthcare AI
  • Speed-to-deployment for emerging research models is typically slow and resource-intensive
man and woman talking
솔루션

BYOM and nPath bring Delphi 2M to life on Teradata in 3 days

Delphi 2M's researchers made a clever architectural innovation: replacing the positional encoding in a standard transformer model—which tracks word order in a sentence—with age encoding that tracks a patient's timeline. Fed with restructured longitudinal patient data, the resulting model can predict future disease onset with remarkable accuracy. Teradata's BYOM technology enabled the engineering team to deploy this small, fine-tuned model directly in-database, while nPath provided the sequencing analytics needed to structure patient journey data—all operational within three days of the paper's release. 

  • Positional encoding replaced with age encoding to process patient timelines as sequences
  • Longitudinal patient data restructured and fed to the model for cohort-level predictions
  • BYOM deploys the 2M-parameter model in-database—faster and cheaper to score than large models
  • nPath handles complex patient sequence analytics natively within Teradata


healthcare professionals
결과

AI-driven healthcare planning that is faster, cheaper, and already accurate enough to act on

While Delphi 2M is still early-stage research and not yet cleared for individual clinical use, it’s already accurate enough for aggregate demand forecasting—helping healthcare systems anticipate which services different cohorts will need across different regions. Running on Teradata, the model delivers this at a fraction of the cost and complexity of large language model alternatives, with the potential to fundamentally transform how health systems plan and fund care. 

  • 3 days from research publication to live deployment on Teradata—a record-speed proof of platform agility
  • 70% accuracy in disease onset prediction 10 years ahead—sufficient for population-level healthcare demand planning
  • Lower cost small model inference in database delivers enterprise AI at a fraction of large model running costs

연결하자

테라데이타 가 비즈니스 성과를 가속화하고 필요한 비즈니스 민첩성을 제공하는 데 어떻게 도움이 되는지 알아보십시오.

영업 담당자가 도와드리겠습니다.



I consent that Teradata Corporation, as provider of this website, may occasionally send me Teradata Marketing Communications emails with information regarding products, data analytics, and event and webinar invitations. I understand that I may unsubscribe at any time by following the unsubscribe link at the bottom of any email I receive.

Your privacy is important. Your personal information will be collected, stored, and processed in accordance with the Teradata Global Privacy Statement.